Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of the study is to determine if clear cell renal cell cancer (RCC) subtype predicts efficacy in percutaneous radiofrequency (RF) ablation of RCC.

Methods and materials

Patients who underwent percutaneous RF ablation for histologically proven RCC subtypes were retrospectively reviewed. Group comparisons were done using univariate and multivariate logistic regression analysis to determine factors impacting primary, secondary, and total technique effectiveness. A p value less than 0.05 was considered significant.

Results

One hundred pathologically proven RCC lesions in 84 patients were analyzed. The median (mean) follow-up was 24 (27) months (range 1–106 months). Overall RF ablation primary, secondary and total technique effectiveness was 86%, 9%, and 95%, respectively. Clear cell subtype demonstrated worse treatment efficacy with primary, secondary, and total technique effectiveness of 42/55 (76.4%), 8/55 (14.5%), and 50/55 (90.9%), respectively. Non-clear cell subtypes had primary, secondary, and total technique effectiveness of 44/45(97.8%), 1/45 (2.2%), 45/45 (100%), respectively. The difference in primary (p = 0.002), secondary (p = 0.032), and total (p = 0.038) technique effectiveness between the two groups was statistically significant.

Conclusion

Clear cell RCC was a novel predictor of primary, secondary, and total technique efficacy in the percutaneous RF ablation of clear cell RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amin MB, Tamboli P, Javidan J, et al. (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3):281–291

    Article  PubMed  Google Scholar 

  2. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27(5):612–624

    Article  PubMed  Google Scholar 

  3. Motzer RJ, Hutson TE, Tomczak P, et al. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356(2):115–124

    Article  CAS  PubMed  Google Scholar 

  4. Choueiri TK, Plantade A, Elson P, et al. (2008) Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. J Clin Oncol 26(1):127–131

    Article  CAS  PubMed  Google Scholar 

  5. Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R (2001) Group EOfRaToCEG. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358(9286):966–970

    Article  CAS  PubMed  Google Scholar 

  6. Flanigan RC, Salmon SE, Blumenstein BA, et al. (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345(23):1655–1659

    Article  CAS  PubMed  Google Scholar 

  7. Simone G, Tuderti G, Ferriero M, et al. (2016) Papillary type 2 versus clear cell renal cell carcinoma: survival outcomes. Eur J Surg Oncol 42(11):1744–1750

    Article  CAS  PubMed  Google Scholar 

  8. Campbell SC, Novick AC, Belldegrun A, et al. (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279

    Article  PubMed  Google Scholar 

  9. Ljungberg B, Cowan NC, Hanbury DC, et al. (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398–406

    Article  PubMed  Google Scholar 

  10. Lay AH, Faddegon S, Olweny EO, et al. (2015) Oncologic efficacy of radio frequency ablation for small renal Masses: clear cell vs papillary subtype. J Urol 194(3):653–657

    Article  PubMed  Google Scholar 

  11. McClure TD, Chow DS, Tan N, et al. (2014) Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. J Vasc Interv Radiol 25(11):1682–1688 (quiz 1689)

    Article  PubMed  Google Scholar 

  12. Ahmed M (2014) Radiology TACotSoI. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update: supplement to the consensus document. J Vasc Interv Radiol 25(11):1706–1708

    Article  PubMed  Google Scholar 

  13. Gervais DA, McGovern FJ, Wood BJ, et al. (2000) Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217(3):665–672

    Article  CAS  PubMed  Google Scholar 

  14. Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853

    Article  PubMed  Google Scholar 

  15. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gervais DA, McGovern FJ, Wood BJ, et al. (2000) Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217(3):665–672

    Article  CAS  PubMed  Google Scholar 

  17. Farrell MA, Charboneau WJ, DiMarco DS, et al. (2003) Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 180(6):1509–1513

    Article  CAS  PubMed  Google Scholar 

  18. Pavlovich CP, Walther MM, Choyke PL, et al. (2002) Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 167(1):10–15

    Article  PubMed  PubMed Central  Google Scholar 

  19. Psutka SP, Feldman AS, McDougal WS, et al. (2012) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63(3):486–492

    Article  PubMed  Google Scholar 

  20. Frank I, Blute ML, Cheville JC, et al. (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170(6 Pt 1):2217–2220

    Article  PubMed  Google Scholar 

  21. Tan YK, Best SL, Olweny E, et al. (2012) Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol. Urology 79(4):827–830

    Article  PubMed  Google Scholar 

  22. Goldberg SN, Grassi CJ, Cardella JF, et al. (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S377–S390

    Article  PubMed  Google Scholar 

  23. Volpe A, Finelli A, Gill IS, et al. (2012) Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62(3):491–504

    Article  PubMed  Google Scholar 

  24. Kroeze SG, van Melick HH, Nijkamp MW, et al. (2012) Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model. BJU Int. 110((6 Pt B)):E281–E286

    Article  PubMed  Google Scholar 

  25. Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453

    Article  PubMed  Google Scholar 

  26. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C (2004) Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 171(5):1802–1805

    Article  PubMed  Google Scholar 

  27. Shannon BA, Cohen RJ, de Bruto H, Davies RJ (2008) The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 180(4):1257–1261 (discussion 1261)

    Article  PubMed  Google Scholar 

  28. Schmidbauer J, Remzi M, Memarsadeghi M, et al. (2008) Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53(5):1003–1011

    Article  PubMed  Google Scholar 

  29. Lebret T, Poulain JE, Molinie V, et al. (2007) Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol. 178((4 Pt 1)):1184–1188 (discussion 1188)

    Article  PubMed  Google Scholar 

  30. Volpe A, Mattar K, Finelli A, et al. (2008) Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 180(6):2333–2337

    Article  PubMed  Google Scholar 

  31. Wang R, Wolf JS, Wood DP, Higgins EJ, Hafez KS (2009) Accuracy of percutaneous core biopsy in management of small renal masses. Urology 73(3):586–590 (discussion 590–581)

    Article  PubMed  Google Scholar 

  32. Veltri A, Garetto I, Tosetti I, et al. (2011) Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol 21(2):393–401

    Article  PubMed  Google Scholar 

  33. Leveridge MJ, Finelli A, Kachura JR, et al. (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60(3):578–584

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of California, Los Angeles, USA

    Timothy McClure, James Sayer & Steven Raman

  2. Department of Urology and Radiology, Weill Cornell Medicine, 525 East 68th Street, Starr 946, New York, NY, 10065, USA

    Timothy McClure

  3. Department of Urology, University of California, Los Angeles, USA

    Allan Pantuck

Authors
  1. Timothy McClure
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan Pantuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Sayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven Raman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy McClure.

Ethics declarations

Conflict of interest

There are no disclosures.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McClure, T., Pantuck, A., Sayer, J. et al. Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype. Abdom Radiol 43, 1472–1477 (2018). https://doi.org/10.1007/s00261-017-1322-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-017-1322-1

Keywords

Search

Navigation